NCT03621020View on ClinicalTrials.gov

Clinical Performance Evaluation of T-TAS 01 PL Chip

CompletedOBSERVATIONAL
Enrollment

307

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

February 14, 2020

Study Completion Date

February 14, 2020

Conditions
Platelet DysfunctionVon Willebrand DiseasesHealthyCongenital Platelets Abnormality
Interventions
DIAGNOSTIC_TEST

T-TAS 01 PL Chip

Flow chamber microchip system specific for measuring primary hemostatic ability

DIAGNOSTIC_TEST

PFA-100 Col/Epi and Col/ADP

System for measuring platelet dysfunction

Trial Locations (6)

21093

Inova Cardiology Baltimore, Lutherville

21215

Sinai Hospital of Baltimore, Baltimore

22042

Inova Heart and Vascular Institute, Falls Church

52242

University of Iowa, Iowa City

92131

Centre Hospitalier Universitaire de Bordeaux, Bordeaux

94112

San Francisco General Hospital, San Francisco

All Listed Sponsors
collaborator

Fujimori Kogyo Co., Ltd.

UNKNOWN

lead

Hikari Dx, Inc.

OTHER

NCT03621020 - Clinical Performance Evaluation of T-TAS 01 PL Chip | Biotech Hunter | Biotech Hunter